Should new health technology be available only for patients able and willing to pay?
New health technology comes on the market at a rapid pace and – sometimes – at a huge cost. Providing access to new health technology is a serious challenge for many countries with mandatory health insurance. This article analyses access to new health technology in Belgium and the Netherlands, using...
Main Authors: | Piet Calcoen, Albert Boer, Wynand P.M.M. van de Ven |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-01-01
|
Series: | Journal of Market Access & Health Policy |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/20016689.2017.1315294 |
Similar Items
-
Managing Urban Stroke Health Expenditures in China: Role of Payment Method and Hospital Level
by: Yong Yang, et al.
Published: (2022-11-01) -
Use of high-level health facilities and catastrophic expenditure in Vietnam: can health insurance moderate this relationship?
by: Hwa-Young Lee, et al.
Published: (2019-05-01) -
Catastrophic health expenditure of Vietnamese patients with gallstone diseases – a case for health insurance policy revaluation
by: Tran BX, et al.
Published: (2019-02-01) -
Healthcare Financing in Saudi Arabia: Recent Trend and Future Challenges
by: Mohammad Faleh Alharbi, et al.
Published: (2022-07-01) -
Contemporary Universal Health Coverage in India – The Case of Federal State of Odisha (Orissa)
by: Sahoo PM, et al.
Published: (2023-06-01)